Zolmitriptan Versus Sumatriptan for the Acute Oral Treatment of Migraine: A Randomized, Double-Blind, International Study

European Journal of Neurology - United Kingdom
doi 10.1046/j.1468-1331.2001.00218.x
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Wiley

Related search

A Double-Blind, Randomized, Multicenter, Italian Study of Frovatriptan Versus Almotriptan for the Acute Treatment of Migraine

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2011English

Intramuscular Versus Oral Dexamethasone for the Treatment of Moderate-To-Severe Croup: A Randomized, Double-Blind Trial

Academic Emergency Medicine
MedicineEmergency Medicine
2003English

Multimechanistic (Sumatriptan-Naproxen) Early Intervention for the Acute Treatment of Migraine

Neurology
Neurology
2009English

Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies

Headache
Neurology
2019English

Eptinezumab in Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (PROMISE-1)

Cephalalgia
MedicineNeurology
2020English

HL301 in the Treatment of Acute Bronchitis: A Phase 2b, Randomized, Double-Blind, Placebocontrolled, Multicenter Study

Korean Journal of Internal Medicine
Internal Medicine
2020English

Aripiprazol Versus Quetiapine in Treatment of Non-Affective Acute Psychosis: A Double-Blind, Randomized - Controlled Clinical Trial

American Journal of Psychiatry and Neuroscience
2017English

Quetiapine Versus Haloperidol in the Treatment of Delirium: A Double-Blind, Randomized, Controlled Trial

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2013English

EHMTI-0031. Efficacy and Safety of Venlafaxine for the Treatment of Chronic Migraine: A Randomized, Double-Blind, Controlled Trial

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy